↓ Skip to main content

HER2 genomic amplification in circulating tumor DNA and estrogen receptor positivity predict primary resistance to trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer

Overview of attention for article published in Breast Cancer, April 2018
Altmetric Badge

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
71 Mendeley